These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 17873348)

  • 1. Wnt signaling, stem cells, and the cellular origin of breast cancer.
    Lindvall C; Bu W; Williams BO; Li Y
    Stem Cell Rev; 2007 Jun; 3(2):157-68. PubMed ID: 17873348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt and mammary stem cells: hormones cannot fly wingless.
    Roarty K; Rosen JM
    Curr Opin Pharmacol; 2010 Dec; 10(6):643-9. PubMed ID: 20810315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key signaling nodes in mammary gland development and cancer: β-catenin.
    Incassati A; Chandramouli A; Eelkema R; Cowin P
    Breast Cancer Res; 2010; 12(6):213. PubMed ID: 21067528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
    Zhang J; Li Y; Liu Q; Lu W; Bu G
    Oncogene; 2010 Jan; 29(4):539-49. PubMed ID: 19881541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
    Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
    J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.
    Meier-Abt F; Milani E; Roloff T; Brinkhaus H; Duss S; Meyer DS; Klebba I; Balwierz PJ; van Nimwegen E; Bentires-Alj M
    Breast Cancer Res; 2013 Apr; 15(2):R36. PubMed ID: 23621987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis.
    Lindvall C; Evans NC; Zylstra CR; Li Y; Alexander CM; Williams BO
    J Biol Chem; 2006 Nov; 281(46):35081-7. PubMed ID: 16973609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells.
    Woodward WA; Chen MS; Behbod F; Alfaro MP; Buchholz TA; Rosen JM
    Proc Natl Acad Sci U S A; 2007 Jan; 104(2):618-23. PubMed ID: 17202265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
    Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
    PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.
    Du Z; Podsypanina K; Huang S; McGrath A; Toneff MJ; Bogoslovskaia E; Zhang X; Moraes RC; Fluck M; Allred DC; Lewis MT; Varmus HE; Li Y
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17396-401. PubMed ID: 17090666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary development and breast cancer: the role of stem cells.
    Ercan C; van Diest PJ; Vooijs M
    Curr Mol Med; 2011 Jun; 11(4):270-85. PubMed ID: 21506923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
    Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
    Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RUNX2 in mammary gland development and breast cancer.
    Ferrari N; McDonald L; Morris JS; Cameron ER; Blyth K
    J Cell Physiol; 2013 Jun; 228(6):1137-42. PubMed ID: 23169547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem/progenitor cells in mouse mammary gland development and breast cancer.
    Li Y; Rosen JM
    J Mammary Gland Biol Neoplasia; 2005 Jan; 10(1):17-24. PubMed ID: 15886883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both LRP5 and LRP6 receptors are required to respond to physiological Wnt ligands in mammary epithelial cells and fibroblasts.
    Goel S; Chin EN; Fakhraldeen SA; Berry SM; Beebe DJ; Alexander CM
    J Biol Chem; 2012 May; 287(20):16454-66. PubMed ID: 22433869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage.
    Badders NM; Goel S; Clark RJ; Klos KS; Kim S; Bafico A; Lindvall C; Williams BO; Alexander CM
    PLoS One; 2009 Aug; 4(8):e6594. PubMed ID: 19672307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cells and the Differentiation Hierarchy in Mammary Gland Development.
    Fu NY; Nolan E; Lindeman GJ; Visvader JE
    Physiol Rev; 2020 Apr; 100(2):489-523. PubMed ID: 31539305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.
    Korkaya H; Paulson A; Charafe-Jauffret E; Ginestier C; Brown M; Dutcher J; Clouthier SG; Wicha MS
    PLoS Biol; 2009 Jun; 7(6):e1000121. PubMed ID: 19492080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Journal of Mammary Gland Biology and Neoplasia. Preface.
    Ingman WV
    J Mammary Gland Biol Neoplasia; 2014 Jul; 19(2):147-8. PubMed ID: 24989703
    [No Abstract]   [Full Text] [Related]  

  • 20. MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists.
    Lv C; Li F; Li X; Tian Y; Zhang Y; Sheng X; Song Y; Meng Q; Yuan S; Luan L; Andl T; Feng X; Jiao B; Xu M; Plikus MV; Dai X; Lengner C; Cui W; Ren F; Shuai J; Millar SE; Yu Z
    Nat Commun; 2017 Oct; 8(1):1036. PubMed ID: 29051494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.